Overview
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2021-05-20
2021-05-20
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to assess the efficacy, onset and duration of analgesia of sphenopalatine ganglion bock (SPGB) using lidocaine 4% with adrenaline as a treatment of postoperative Post dural puncture headache (PDPH) of orthopedic patients after lower limbs surgeries.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Tanta University
Criteria
Inclusion Criteria:- Admitted to the orthopedic department
- Complaining of criteria of severe post-dural puncture headache within 7 days following
subarachnoid block used for lower limbs surgeries.
- American Society of Anesthesiologists (ASA) physical status I and II.
Exclusion Criteria:
- Patient refusal or uncooperative.
- Patients with uncontrollable hypertension.
- Patient with known coagulopathy.
- Patient with nasal septal deviation, polyp, history of nasal bleeding.
- Patient with allergy to local anesthetics
- American Society of Anesthesiologists physical status>2.